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Abstract  
Controlled substance abuse is a global epidemic. Several factors that influence health 
care providers prescribing habits have been presented in recent literature. However, the 
existing evidence primarily reflects the prescribing habits of physicians, while relatively 
little is known about the prescribing habits of nurse practitioners. The purpose of this 
project is to evaluate the impact of a brief web-based continuing education module 
targeting appropriate prescribing of controlled substances for recent graduate nurse 
practitioners. The project served to assess the provider’s knowledge, attitude, and practice 
compared to current integrated curriculum on prescribing and assess change in 
knowledge. Two online educational modules and associated Pre and Post-Test knowledge 
assessments, Demographics survey, and Course Evaluation survey were conducted on a 
total of 22 new graduate nurse practitioners from Belmont University’s family nurse 
practitioner program. Results were obtained, analyzed, and coded using Qualtrics Survey 
Software, IMB SPSS Statistics Version 23 and by direct item analysis. The mean 
knowledge score of participants significantly increased after completing the online 
educational intervention. Most participants (63.6%) reported feeling adequately prepared 
by their graduate level pharmacology course to prescribe controlled substances, however, 
over three fourths of participants indicated they would “definitely” or “probably” make a 
practice related change. Knowledge deficits pertaining to the ability to classify pain, 
recognizing appropriate adjuvant therapies, utilizing systematic prescribing approaches, 
and the ability to assess, screen, and monitor for substance use disorder (SUD) were 
identified. Despite reports of feeling prepared to properly prescribe, knowledge deficits 
were identified in graduates who have only been exposed to information surrounding 
controlled substance prescribing found in current integrated curriculum. The online 
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educational intervention was found to successful in increasing participant knowledge 
after participation and was reported by respondents to be very practical and applicable to 
clinical practice.  
 
Keywords: opioid analgesics, primary healthcare, providers, attitudes, dosing, guidelines, 
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Introduction and Background  
Controlled substance abuse has become a worldwide problem, in particular opioid 
abuse. In 2012 alone, health care providers wrote an estimated 250 million prescriptions 
for opioid pain medications, enough for every person aged 18 or greater in the United 
States to have a bottle of pills (Centers for Disease Control and Prevention, 2016). This is 
an increase of approximately 170 million prescriptions since 1991 (National institute on 
Drug Abuse, 2014). Since 1999, the number of unintentional overdose deaths from 
prescription opioids has more than quadrupled (National Institute on Drug Abuse, 2014). 
Due to this prescription increase, the potential for drug diversion is higher and there is 
increased risk of inappropriate use, and ultimately user death (Volko, 2015).  
In 1997 the Tennessee Nurses Association (TNA) passed legislation authorizing 
nurse practitioners prescriptive authority of controlled drugs, Schedules II-V (Tennessee 
Nurses Association, n.d.b). Since the passing of this bill, the Tennessee Controlled 
Substance Monitoring Database (TNCSMD) identified that 35 of the top 50 prescribers of 
controlled substances were Advanced Practice Registered Nurses (APRNs), including 
nurse practitioners (Tennessee Nurses Association, n.d.a).  
The American Association of Nurse Practitioners (2017) reports nurse 
practitioners write approximately 23 prescriptions a day and 7,500 prescriptions within a 
given calendar year.  Between the years 2014 and 2015 an estimated 20,000 new nurse 
practitioners successfully graduated from academic programs with the intention of 
passing certification exams and entering the workforce (American Association of Nurse 
Practitioners, 2017). With 83.4% of nurse practitioners being certified in an area of 
primary care and over 50% of opioid prescriptions originating in the primary care setting, 
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assessment of the prescribing practices of new nurse practitioners may contribute to a 
clearer understanding of how this population of prescribers is contributing to the 
epidemic (American Association of Nurse Practitioners, 2017; Hudspeth, 2016). 
Additionally, a clearer understanding of the clinical context in which prescriptions are 
written, as well as the education and training that prepares nurse practitioners as 
prescribers may illuminate how APRN prescribers may be vulnerable to misprescribing. 
 Misprescribing may be purposeful or accidental and occur for a multitude of 
reasons. Prescribers can be classified as dishonest are seeking personal financial gain. 
Others may be classified dated in their knowledge, duped by drug-seeking patients, 
dysfunctional due to overextension, or have disregard or disbelief for prescribing 
guidelines, all leading to inappropriate prescribing of controlled substances (Spickard, 
Dodd, Swiggart, Dixon, Pichert, 1998).  
In early 2016, the CDC released standardized opioid prescribing guidelines to 
support safe and responsible prescribing practices. Healthcare provider’s personal 
attitudes and beliefs, legal and practice considerations, and concern over Federal Drug 
Agency (FDA) and Drug Enforcement Agency (DEA) scrutiny have significantly 
impacted their opioid prescribing habits (Chiauzzi, Trudeau, Zacharoff & Bond, 2011; 
Fontana, 2008; Hooten & Bruce, 2011; Spitz, Moore, Papaleontiou, Granieri, Turner, & 
Reid, 2011). However, the body of literature surrounding this topic focuses primarily on 
the prescribing habits of medical doctors, while relatively little is known about whether 
these variables have a similar impact on the prescribing practices of nurse practitioners. 
With approximately 222,000 licensed nurse practitioners in active practice with 
prescriptive authority for controlled substances in all 50 states, it is imperative to consider 
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and assess factors that are unique to this population of prescribers (Department for 
Professional Employees, 2016; American Association of Nurse Practitioners, 2017).  
However, several continuing education methods were successful in furthering 
prescriber knowledge and improving attitudes surrounding controlled substances 
(McCracken, Biochat, &Eccleston, 2012; Roth& Burgess, 2008; Srivastava, Kahan, & 
Jiwa, 2012) 
The Center for Professional Health (2016) (CPH) at Vanderbilt University in 
Nashville, Tennessee was established in 1998 to help physicians who needed behavioral 
intervention and remediation related to their own substance abuse or the inappropriate 
prescribing of controlled substances and to provide the Tennessee Board of Medical 
Examiners with new options for physician remediation (Bill Swiggart, personal 
communication, February 11, 2016). In the eighteen years since, CPH has served more 
than 1,150 physicians from all over the United States and has developed a body of 
research on the complexity of responsible prescribing, the psychological roots of 
inappropriate prescribing and the unique challenges of clinicians who suffer from 
substance abuse disorder (SUD).  After years of research the Center for Professional 
Health (2016) discovered the reasons for misprescribing were multi-factorial and were 
able to group misprescribers into categories based on the reason for misprescribing. Thus, 
remediation and intervention required deep introspection, reflection, SUD treatment 
where necessary, and ongoing counseling and support.  
Problem Statement  
Despite increased regulation and guidance, nurse practitioners continue to be 
among the top prescribers of controlled substances. To ensure our professional 
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responsibility related to prescribing, it is imperative to assess the factors that influence 
this unique population of controlled substance prescribers.  
Purpose 
The purpose of this scholarly project is to evaluate the efficacy of The Center for 
Professional Health’s continuing education modules on appropriate prescribing of 
controlled substances for recent graduate nurse practitioners and assess the provider’s 
knowledge, attitude, and practice compared to current integrated curriculum on 
prescribing. The objective of this study is to determine if pre and post-tests reveal an 
increase in the provider’s knowledge, a change in attitude toward prescribing controlled 
substances, and reveal any intended change in practice after reviewing the educational 
modules. Additionally, this project is piloting the web based modules as an appropriate 
and desirable format for targeting new providers within the first five years of practice to 
increase knowledge surrounding controlled substance prescribing.  
Review of Evidence  
Guidelines 
In early 2016 the CDC published The CDC Guideline for Prescribing Opioids for 
Chronic Pain to provide health care providers with evidence-based recommendations for 
the prescribing of pain medications for persons aged 18 years or greater in the primary 
health care setting (CDC, 2016). The guidelines focus on the use of opioid analgesics in 
the treatment of chronic, non-cancer, non-palliative care pain. The guidelines consists of 
12 recommendations, each with an evidence-based rational. The CDC (2016) reports the 
recommendations were formed by systematic review of scientific evidence, while still 
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allowing consideration for the associated benefits and harms, values and preferences, and 
resource allocation.  
The Tennessee Department of Mental Health and Substance Abuse Services 
(2014) has employed a statewide opioid prescribing guideline as well as strategies to 
prevent and treat prescription drug abuse in the state. However, persistent prescribing, 
diversion and accidental overdose in both the state and nation suggests awareness and 
application of guidelines alone is not sufficient to change providers’ prescribing habits.  
Factors Influencing Prescriber Habits  
Several articles presented factors that influence prescribers, including knowledge, 
personal attitude and beliefs, legal and practice considerations, and concerns of DEA and 
FDA scrutiny (Chiauzzi, Trudeau, Zacharoff & Bond, 2011; Fontana, 2008; Hooten & 
Bruce, 2011; Spitz, Moore, Papaleontiou, Granieri, Turner, & Reid, 2011).  
Knowledge. Chiauzzi, Trudeau, Zacharoff and Bond (2011) consulted sixteen 
nationally recognized experts in primary care, pain management, and addiction medicine 
and identified knowledge, skills, and competencies most influential and critical for 
primary care providers to effectively manage patients taking opioid analgesics. General 
knowledge surrounding monitoring urine drug screens was the single most important skill 
needed to properly treat and manage patients taking controlled substances. Knowledge 
pertaining to assessment of risky behavior in patients ranked second and interpersonal 
skills was third.  
 Fontana (2008) found that APRN’s prescriptive choices were influenced in part 
by knowledge of the etiology of the pain. Participants reported this knowledge was 
obtained from their formal education and hands on clinical experience. However, 
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participants also reported feeling as though integrated curriculum on pain management 
and pharmacology pertaining to controlled substances was not adequate in comparison to 
the volume of patients seen for pain related complaints (Fontana, 2008). Hooten and 
Bruce’s (2011) survey participants also reported the lack of formal education on the topic 
manifested itself in feelings of fear related to causing addiction in patients.  
 Spitze, Moore, Papaleontiou, Granieri, Turner, and Reid (2011) found that 
prescribers consider numerous patient factors when deciding to prescribe an opioid, 
including the provider’s subjective experience of patient reliability, presence of a reliable 
caregiver, etiology of the pain, and a documented history of benefiting from opioid 
therapy. Providers were more likely to prescribe opioid therapy if the patient was reliable 
or had a reliable caregiver to administer the medication, an identifiable etiology of pain, 
and a history of successful opioid therapy. Likewise, Spitze, Moore, Papaleontiou, 
Granieri, Turner, and Reid (2011) found providers were less likely to prescribe an opioid 
if the patient had cognitive impairment, history of polypharmacy, or no reliable caregiver.  
Personal attitudes & beliefs. The focus group of nurse practitioners in Fontana’s 
(2008) study reported reluctance to prescribe certain medications if they or a family 
member had a negative experience with the specific drug. In conjunction with Fontana 
(2008), Spitze, Moore, Papaleontiou, Granieri, Turner, and Reid (2011) also found if a 
practitioner had a prior clinical experience or personal experience with a painful 
condition, he/she was more likely to prescribe opioid analgesics to the patient. In 
addition, participants connected relying on their personal experience with a general lack 
of formal education pertaining to controlled substance prescribing (Fontana, 2008). All 
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participants reported believing better formal education in pain management would help 
them better meet the needs of their patients (Fontana, 2008).  
Spitze, Moore, Papaleontiou, Granieri, Turner, and Reid (2011) conducted a focus 
group composed of 23 physicians and three nurse practitioners that revealed all providers 
reported feeling cautious and uneasy when prescribing controlled substances.  
Hooten and Bruce (2011) distributed a questionnaire to 128 medical doctors and 
APRN’s and found that 27% of respondents believed that prescribing opioids could lead 
to abusive behavior, patient addiction, and have an unfavorable impact on their clinical 
practice. Overall Hooten and Bruce (2011) found that a large proportion of respondents 
reported a negative attitude toward patients with abusive behavior and addiction, as well 
as a negative attitude toward the effects of prescribing opioids on the complexity of 
patient care. Prescribers reported that adding opioid therapy would increase the level of 
management related to polypharmacy, the management of comorbid conditions, and 
result in the need to obtain a more complex patient history.  
Legal & practice considerations. Fontana (2008) revealed that many participants 
felt constrained by their clinical practice setting and felt it necessary to protect one’s self 
from the perceived personal risk involved with prescribing opioids. This protection 
involved each practitioner assessing his/her own best interest, in relation to his/her role 
within the clinical practice. Within certain practice settings practitioners must adhere to 
protocols that do not allow for the personal consideration of practitioner (Fontana, 2008).  
DEA & FDA scrutiny. Fontana (2008) critically examined subjective factors that 
influence the prescribing habits of APRN’s, finding that clinicians often act in their own 
best interest to reduce the risk of DEA scrutiny. Participants reported fear of DEA 
PROPER PRESCRIBING OF CONTROLLED DRUGS 12 
scrutiny even in situations where the pharmacologic choice was appropriate (Fontana, 
2008). Hooten and Bruce (2011) and Spitze, Moore, Papaleontiou, Granieri, Turner, and 
Reid (2011) also found that respondents are concerned about regulatory FDA scrutiny 
when prescribing controlled substances.  
Tennessee Requirements & Curriculum Audit  
In order to obtain prescriptive authority in Tennessee, the state Board of Nursing 
requires a minimum of three quarter hours of graduate level pharmacology instruction in 
addition to a current unencumbered license as a registered nurse, a current national 
certification in the appropriate nursing specialty area, and graduation from a master’s or 
doctoral level nursing program (Tennessee Code Ann. §63-7-207). In order to prescribe 
controlled substances, one must contact the Drug Enforcement Agency (DEA) and 
complete the designated application before being issued a DEA number. The Tennessee 
State Board of Nursing now requires two contact hours of continuing medical education 
(CME) addressing controlled substance prescribing specifically as a requisite for the 
renewal of the APRN license (Tennessee Code Ann. §1000-4-.05).  
Nurse practitioners in Tennessee are required to renew certification every five 
years; during the first years of practice, new graduate nurse practitioners rely on 
information presented on controlled substances during the advanced pharmacology 
portion of his/her graduate education course (Tennessee Code Ann. §1000-4-.05).  In 
Belmont University’s family nurse practitioner program there is one pre-class, voice-over 
PowerPoint dedicated to the legal aspects of prescribing in Tennessee, one in-class 
PowerPoint specific to analgesics, and a review of the CRAFFT Substance Abuse Screen 
mnemonic tool. Within the analgesic PowerPoint, there are 16 slides specifically 
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dedicated to controlled substances. Formal instruction and practice related to screening 
for SUD in primary care is focused illicit drug and alcohol abuse and is not related to 
controlled substance prescribing or pain management.  
While this curriculum meets the standards set forth by the Tennessee Code Ann. 
§63-7-207, whether this amount of information adequately prepares nurse practitioners to 
properly prescribed controlled substances is unknown. Full application of the skills 
surrounding controlled substance prescribing cannot be applied until the student has 
successfully graduated, received a DEA number, and is in active clinical practice; this 
process is on average one to two years after this information is initially presented in 
Belmont University Graduate School of Nursing’s pharmacology course.  
Educational Intervention 
 The need for continuing education and readily accessible guidelines is well 
established in the literature. As a result, researchers have been working to implement new 
interventions aimed to fill the identified gaps in knowledge and skills.  
McCracken, Biochat, and Eccleston (2012) found that the demand for further 
opioid education including both pain pathology and prescribing practices is high. The 
authors also found that participants of the training intervention reported the Acceptance 
and Commitment Therapy (ACT)-based educational intervention was more interesting 
and engaging than the traditional standard education intervention. ACT training focuses 
primarily on psychological flexibility, which entails the ability to act in accordance with 
goals and values while minimizing influence from cognitive or emotional experiences 
(McCracken, Biochat, and Eccleston, 2012). This suggests that health care professionals 
prefer experiential exercises and the emotionally evocative methods of ACT to more 
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passive didactic learning activities. The authors also report that participants showed an 
increase in knowledge of controlled substance prescribing immediately post-intervention 
and two weeks later, as evidenced by post-test results. Participants also reported having 
an overall decrease of concern about addiction, professional scrutiny, and increased 
controlled substance prescribing knowledge (McCracken, Biochat, & Eccleston, 2012). 
 Roth and Burgess (2008) also found that after attending an educational workshop 
grounded in adult learning theory, participants reported significantly less fear of causing 
addiction in patients, and less concern for professional and legal scrutiny related to 
prescribing controlled substances.  
 Srivastava, Kahan, and Jiwa (2012) led a prospective cohort pilot study evaluating 
the feasibility and effectiveness of a multifaceted educational intervention to improve the 
opioid prescribing practices of physicians. Participants reported the didactic and case 
discussion facet to be most helpful and enjoyable, while the e-mail and online chat room 
were the least useful. Participants in this study reported increased application of treatment 
guidelines, including routing screening for misuse and abuse after the educational 
intervention.  
Since CPH was formed over a decade ago, it has served over 1,150 providers, but 
primarily physicians (Brown, Swiggart, Dewey, & Ghulyan, 2012; Charlene Dewey, 
personal communication, February 11, 2016). Since 1997, when mid-level prescribers 
gained prescriptive authority of scheduled drugs, The Center for Professional Health saw 
an increase in the number of nurse practitioners and physician assistants attending the 
remediation course (Bill Swiggart, personal communication, February 11, 2016). The 
increase in nurse practitioner and physician assistant prescribers has lead The Center for 
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Professional Health at Vanderbilt University to create the Proper Prescribing of 
Controlled Prescription Drugs for Advanced Practice Nurses course aimed specifically at 
this population (Charlene Dewey, personal communication, February 11, 2016).  
Theoretical Model 
Theoretical Model Overview & Concepts  
In the 1950’s Donald Kirkpatrick developed the Kirkpatrick Evaluation Model to 
objectively assess the efficacy and impact of a training intervention. The Kirkpatrick 
Evaluation Model evaluates the value of any type of training transversely across four 
levels: reaction, learning, behavior, and results (Kirkpatrick Partners, 2016) (See Figure 
1).  
The Vanderbilt University Center for Professional Health (CPH) utilizes this 
model as the framework for assessing the effectiveness of the Proper Prescribing of 
Controlled Prescription Drugs for Tennessee course in the classroom setting. Because 
this Scholarly Project is a pilot study containing materials presented in the CPH course, 
exact replication of the theoretical framework was necessary and no changes were made.  
Level 1 assesses the reaction of the participants and the degree to which they 
found the training to be favorable and relevant; Level 2 assesses the degree to which 
participants acquired the intended knowledge, skills, and attitude (Kirkpatrick Partners, 
2016). Level 3 assesses the degree to which participants apply the material obtained 
during the training and Level 4 assesses the degree to which the desired outcomes occur 
as a result of the training (Kirkpatrick Partners, 2016).  
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Assumptions  
Since the proposal and development of the Kirkpatrick Evaluation Model 
researchers and trainers have identified three main assumptions that appear unintended by 
Kirkpatrick himself.  
The first assumption is that the levels are arranged in ascending value. Meaning, 
the measure of Level 2- Learning, provides more information than the measure of Level 
1- Reaction, and so forth (Alliger & Janak, 1998). The second assumption is that these 
levels of evaluation are causally linked. This linkage denotes that a training intervention 
leads to reaction, which leads to learning, which leads to behavior, which leads to results. 
The third and final assumption is that the levels are positively inter-correlated. That is, a 
set of positive interrelationships exist between the various evaluation levels (Alliger & 
Janak, 1998).  Each of these assumptions stems from the idea that the Kirkpatrick 
Evaluation Model is a hierarchical model of training evaluation.  
Theory Application  
Kirkpatrick Evaluation Model is being utilized as the framework for this 
Scholarly Project because of the step-by-step assessment of the effectiveness of a training 
intervention. Levels 1, 2, and 3 of the Kirkpatrick Evaluation Model have been applied to 
this Scholarly Project.  
Level 1- Reaction, was applied by assessing the degree to which the participants 
found this educational intervention to be useful. Four questions in the Course Evaluation 
Survey assess the participant’s perspective of the overall quality of the information, the 
perceived individual value, and the degree to which the individual’s needs were met. 
Level 2- Learning, was applied by assessing the participant’s Pre and Post-Test Survey 
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answers associated with each educational module. A correct change in answer from the 
Pre-Test to Post-Test indicates that learning of the desired material has taken place.  
Level 3-Behavior, was applied to the project by assessing the participant’s 
intended behavior change. Two questions in the Course Evaluation Survey assess the 
participant’s intended change in practice and personal change. Level 4- Results, was not 
applied in this project, but will inform recommendations at the conclusion of the project. 
Due to the short implementation period of the project, it was not feasible to assess the 
long-term changes in prescriber behavior that occur after the educational intervention.  
Project Design 
This study was designed to pilot an online educational intervention for nurse 
practitioner prescribers. The Project Leader used a cross-sectional, survey-based design 
to evaluate the effectiveness of the intervention. Participant pre and post intervention 
knowledge were measured immediately before and after the educational modules were 
completed. A Demographics and Course Evaluation Survey were also completed to 
determine participant satisfaction. The dependent variables of the study included 
participant knowledge, attitude, and intent to change practice, all of which are ordinal 
level measurements. All nominal level measurements obtained through multiple-choice 
survey and demographic questions represented the independent variables. This project 
was verified as exempt by Belmont University’s Institutional Review Board.  
Project Population  
All participants of this study were licensed nurse practitioners in the United States 
who graduated from Belmont University’s Graduate School of Nursing between 
December 2011 and May 2015. This sample represents new nurse practitioners who are 
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in active clinical practice, but have not yet recertified and completed continuing 
education hours related to controlled substance prescribing per the recertification 
requirements found in the Tennessee Code Ann. §1000-4-.05. A purposive sample of 
potential participants was identified through Belmont University’s Alumni directory, 
accessed with permission from the Belmont University Alumni Association. Each 
participant provided informed consent by voluntarily agreeing to participate in the study. 
All participants were given full access to the two modules, there was no control group 
assigned.  
Inclusion criteria included: 1) successful completion and graduation from 
Belmont University’s Graduate School of Nursing and 2) date of graduation between 
December 2011 and May 2015. Exclusion criteria included: 1) graduates who 
participated in the post-masters graduate program. These graduates were not eligible for 
participation because it is unknown if he/she graduated from Belmont University’s 
masters degree program prior to attending Belmont’s post-masters to Doctor of Nursing 
Practice program.  
Project Setting and Educational Intervention 
 Vanderbilt University’s Center for Professional Health creates online learning 
modules to capture the content of the on-campus controlled substance prescribing 
continuing medical education (CME), but in a format that is more cost effective and 
accessible to a larger audience (Charlene Dewey, personal communication, February 11, 
2016). It is important to note providers, including nurse practitioners, who register for the 
on-campus program have already been identified by his/her governing body as having 
irresponsible prescribing habits. Participation in the course is often mandatory and 
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required to have their license re-instated. Offering this content online to new nurse 
practitioners before recertification requirements represents an upstream intervention 
aimed at early intervention for practitioners before they are identified as irresponsible 
prescribers.  
These modules were developed by Dr. Charlene Dewey, with advanced practice 
registered nurses (APRN’s) in mind but have not yet been disseminated to a larger 
audience. This Scholarly Project pilots two of the online modules developed by the CPH 
to assess for knowledge gain within the designated sample group, indicating this content 
can be used as prevention or early intervention for new nurse practitioners who may be at 
high risk for irresponsible prescribing.  
Learning objectives in Module 1: Overview of Pain and Tennessee Chronic Pain 
Guidelines were related to appropriate classification of pain, adjuvant therapies, 
pharmacologic treatments, and appropriate use of Tennessee chronic pain guidelines. 
Learning objectives in Module 2: Best Clinical Practice were related to targeting and 
screening for SUD and the use of clinical best practices appropriately. 
Sources of Data/Data Collection Instruments  
Two online educational modules and associated Pre and Post-Tests and Course 
Evaluation form from PCH’s Proper Prescribing of Controlled Prescription Drugs for 
Advanced Practice Nurses course were used in this study to determine if participants had 
a change in knowledge, attitude, and/or practice. Module 1: Overview of Pain and TN 
Chronic Pain Guidelines Pre and Post-Test survey was composed of eight multiple-
choice questions and Module 2: Best Practice for Proper Prescribing of CPD Pre and 
Post-Test survey was composed of five multiple-choice questions. The survey questions 
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reflect a high level of rigor and require not only recall of information, but also 
understanding, application, and analysis to draw connections among topics (Armstrong, 
2017). The Course Evaluation survey was composed of seven multiple-choice questions. 
A 12 question Demographics Survey was created to gather additional participant 
information. (See Appendix A for Surveys). 
The two educational modules were made available to participants through Electa 
Live©. Qualtrics survey software was used to distribute the survey questions and to 
collect Pre and Post-Test, Demographic Survey, and Course Evaluation data. Descriptive 
data were analyzed using Microsoft Excel 2011.  
Belmont University’s Graduate School of Nursing curriculum was audited for 
content related to controlled substance prescribing, of which all participants received 
during their education. Participants received comparable content related to controlled 
substance prescribing; minimal adjustments were made annually to ensure content 
accuracy (Leslie Higgins, personal communication, April 25, 2017). Course syllabi, 
objectives, assignments, and evaluation items were assessed for content surrounding the 
assessment and management of acute and chronic pain as well as the legal/regulatory 
implications of controlled substance prescribing.  
Data Collection Process/Procedures 
Data collection took place from October 1 to December 1, 2016. Incentive to 
participate included a $100 Visa gift card drawing. An initial invitational e-mail and 
video was sent to potential participants. Those who accepted the invitation to participate 
were then sent a subsequent e-mail containing directions, as well as a link and username 
and password to access the PowerPoint based modules via the Electa Live© virtual 
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classroom platform. In the directions, the participants were informed both how to access 
Electa Live© and the PowerPoint modules.  The directions also stated that the survey 
links in the slides were to be completed in the order that they appeared and all responses 
were anonymous and contained no identifying information (See Appendix B). All 
Pre/Post-Test, Demographic Survey, and Course Evaluation data was saved using 
Qualtrics for later evaluation and statistical analysis.  
Results  
Of the 114 graduates from Belmont University’s FNP program who were invited 
to participate, 5.18% (N= 22) participated. Of which, 91% (N=20) completed all 
components of the study including the online educational modules, pre and post-tests, and 
demographics survey. Two participants failed to complete the course evaluation (N=20).  
Demographics.  The target population for this project was recent graduates early 
in their careers as nurse practitioners. The socio-demographic characteristics of the 
participants are presented in Table 1. Of the 22 participants, two identified as working in 
urgent care, seven in primary care, one in pain management, six in a specialty practice 
and six in “other” category practices. Over half (N=13) of the respondents reported 
working in an urban setting, while the remaining (N=9) reported working in a rural 
setting. Both years of active clinical practice and length of time at current practice ranged 
from 0 to 5 years; the mean years of active practice was 2.14 years. The average time 
participants had been working in their current clinical practice was 1.73 years. Of the 
participants, eight reported working primarily with the adults, two with geriatrics, one 
with pediatrics, five in mixed primary care, and six in “other” patient populations. The 
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majority of participants, 90.0% (N=20), reported working in the state of Tennessee, while 
4.5% (N= 1) reported Missouri, and 4.5% (N=1) Texas.  
Practice Structure. The reported availability of the supervising physician varied, 
four reported working in a private practice with a supervising physician available by 
phone, three reported working with a group of NP’s with a supervising physician 
available by phone, and fifteen reported working with a supervising physician available 
on site. Over one third (N=17) of respondents reported having protocols in place 
surrounding controlled substance prescribing, while the remaining (N=5) respondents 
reported having no established protocols.    
Controlled Substance Prescribing. Only one respondent reported not 
prescribing controlled substances in clinical practice. Of those remaining, two thirds 
(N=14) reported feeling prepared by the graduate pharmacology course they received at 
Belmont University, while the remaining third (N=7) reported feeling unprepared.  
Item 10 of the Demographic Survey allowed respondents to select all that apply 
regarding major concerns related to controlled substance prescribing. The most 
commonly chosen item was “pressure/demand from patients,” selected thirteen times, 
followed by “continuing a standing prescription written by another provider”, selected ten 
times. Participants chose “treating co-occurring pain and mental health” eight times, 
“other” six times, and “pressure from supervising physician” one time.  Of the 
respondents, six reported either leaving or considering leaving a job due to controlled 
substance prescribing habits at the practice.  
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Module 1 Pre and Post Test Knowledge Assessment.  
Each participant’s Module 1 Pre and Post Test scores were graded for accuracy. 
The total scores were compared to assess whether there was an increase in answer 
accuracy between the Pre and Post Test scores. A Paired t-test was computed on both the 
Pre-Test and Post-Test total scores to assess for an increase in answer accuracy. The 
analysis revealed that the educational intervention significantly increased participant 
knowledge related to controlled substance prescribing. Of the eight items on the Module 
1 Pre-Test, the average total score was five out of eight correct answers.  Of the same 
eight items on the Module 1 Post-Test, the average total score was seven out of eight 
correct answers. The participants gained an average of 1.591 points on the Module 1 
Post-Test, with the average score being 6.59 out of eight correct answers. 
Due to sample size not meeting the 30 participant assumption of the Paired t-test, 
the Wilcoxon matched-pairs test was used to validate statistical significance. In addition, 
the Shapiro-Wilk test for normality was performed and the Wilcoxon matched-pairs test 
was performed due to the measure not being normally distributed (See Table 3). The 
Wilcoxon matched-pairs test concluded that a significant difference (p < .001) existed in 
knowledge score before and after the educational intervention was completed (See Table 
4). 
An item analysis of Module 1 Pre and Post-Tests found there was a knowledge 
deficit in topics pertaining to the following: classifying categories of pain based on 
symptoms and duration of symptoms, as well as adjuvant pain treatment options. These 
deficits were defined by summing the total number of correct answers for each item on 
the survey. Respondents increased individual question scores by greater than or equal to 
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ten points, which indicates an increase of 45% (N=22) over Pre-Test scores (See Table 
5). 
Module 2 Pre and Post Test Knowledge Assessment.  
Of the five items on the Module 2 Pre-Test the average score was 2.45 out of five 
correct answers. The participants gained an average of 2.19 points on the Module 2 Post-
Test, with the average score being 4.64 out of five correct answers. This gain is 
statistically significant at p < .001 by the paired t-test (two-tailed) (See Table 2).  
The item analysis of Module 2 Pre and Post-Tests revealed a knowledge deficit in 
assessing for substance use disorder, employing a systematic approach to prescribing 
controlled substances, and utilizing screening/monitoring tools for patients prescribed 
controlled substances (See Table 6). 
Course Evaluation. Each participant completed a course evaluation survey, 
addressing the overall quality and value of the material.  Of the respondents, 55% (N=11) 
rated the quality of the material presented as “excellent”, and 45% (N=9) reported the 
quality of the material to be “average”.  Over half of the participants (N= 12) felt the 
presented information was “extremely valuable” to them as an individual, and the 
remaining eight felt it was “valuable”.  
After completing the educational modules ten of participants reported that they 
would “probably make a practice related change”, five reported they would “definitely 
make a practice related change,” one reported they would “probably not make a practice 
related change,” and two reported they would “definitely not make a practice related 
change.”  
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Discussion 
Participant Knowledge Score. The main finding of this study was that 
participant knowledge surrounding controlled substance prescribing significantly 
increased after completing the educational modules. This finding is consistent with 
McCracken, Biochat, and Eccleston (2012), who also found an increase in participant 
knowledge and intent to change prescribing practices directly associated with educational 
related to guidelines. This increase in knowledge score from Pre-Test to Post-Test is 
consistent with Level 2-Learning, of the Kirkpatrick Evaluation Model. This indicates 
that the educational intervention influenced increased learning of the desired material.  
Although 63.6% of study participants reported feeling as though their graduate 
level pharmacology course adequately prepared them to prescribe controlled substances 
with confidence, over three fourths of the respondents indicated they would “definitely” 
or “probably” make a practice related change after completing the educational 
intervention. This suggests that despite the perception of adequate graduate level training 
in pharmacology, the intention to change practice suggests that there was content 
presented in the modules that the participants may not have known they were missing. In 
comparison to Module 1, there was a larger increase in Module 2 Post-Test scores 
suggesting information pertaining to systematic prescribing of controlled substances, as 
well as targeting and screening of SUD is missing from graduate level courses, or 
perhaps not presented in a manner that provokes knowledge retention.  
The Tennessee Board of Nursing now requires continuing education credits 
specifically related to controlled substance prescribing in order to renew certification 
licensure every five years (Tennessee Code Ann. §1000-4-.05). This action by the Board 
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of Nursing supports the importance and urgency of nurse practitioners needing this 
information in primary care. The nurse practitioners in this sample represent providers 
new to practice who have not yet completed the required continuing education related to 
controlled substance prescribing, making them and their patients more vulnerable to 
error.  
Consistent with previous literature findings, this study also found knowledge 
deficits to be a factor that could influence prescribing habits (Chiauzzi, Trudeau, 
Zacharoff, & Bond, 2011; Fontana, 2008; Hooten & Bruce, 2011; Spitze, Moore, 
Papaleontiou, Granieri, Turner, & Reid, 2011). Congruent with established literature, this 
study found that practitioner knowledge deficits are present in the ability to classify pain, 
recognize appropriate adjuvant therapies, utilize systematic prescribing approaches, and 
the ability to assess, screen, and monitor for SUD (Chiauzzi, Trudeau, Zacharoff, & 
Bond, 2011; Fontana, 2008).  
This suggests, despite adequate completion of a graduate level family nurse 
practitioner program, there is a significant time lapse between education and autonomous 
practice. There is knowledge attrition that occurs during this time period, which may 
impact prescribing practices. The findings of this study suggest refresher courses may 
significantly increase the knowledge level of nurse practitioners who have not yet been 
required by the Board of Nursing to complete continuing education directly related to 
controlled substance prescribing.  
Leading Concern Surrounding Prescribing. The deficit concerning practitioner 
ability to assess, screen, and monitor for SUD in combination with the most frequently 
reported concern surrounding controlled substance prescribing, the “pressure/demand 
PROPER PRESCRIBING OF CONTROLLED DRUGS 27 
from patients”, further suggests that new nurse practitioners lack the confidence to 
identify and respond to SUD.  
This study directly reports the pressures new nurse practitioners face from 
patients who are seeking controlled substances and highlights the lack of knowledge in 
assessing, screening, and monitoring for SUD in primary care. These findings illuminate 
the unique role nurse practitioners play in the controlled substance abuse epidemic. New 
nurse practitioners and their patients are vulnerable to these complex challenges and may 
benefit from educational interventions targeting both the identified knowledge deficit and 
the development of clinical skills to implement controlled substance guidelines, with 
specific focus on screening for risk of SUD before starting controlled substances, 
recognizing risk of SUD, and intervening appropriately when SUD is suspected or 
confirmed.  
Online Presentation Format.  Although the mean knowledge score of the 
participants increased significantly, the delivery method of the educational modules 
proved to be unappealing to most who were invited to participate. Tjin, Tsoi, de Boer, 
Croiset, Koster, and Kusurkur (2016) report participants find online formatting 
convenient, however face-to-face meetings with peers was an important factor 
influencing participation in healthcare continuing education courses. This is consistent 
with McCracken, Biochat, and Eccleston’s (2012) findings, that health care professionals 
prefer more engaging and emotionally evocative learning methods.   
The low participation rate of this study highlights the challenge associated with 
reaching this target population and the lack of awareness of their current knowledge 
deficit. Often additional education is not sought out until the knowledge deficit has 
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manifested itself as a liability to their professional livelihood or patient safety (Charlene 
Dewey, personal communication February 11, 2016). The low response rate does not 
indicate the quality of the content or even the delivery format is inadequate. In fact, 
retention rates were high as were overall ratings of the material quality. This suggests 
despite the online presentation format, participants were engaged in the content and 
found the information valuable as a health care provider.  
Piloting these modules in an online format was intended to gauge if the ease of 
content accessibility increased the likelihood of participation. While continued research 
needs to be conducted to further assess this presentation method, it can be inferred from 
this study’s findings that the online format is successful in yielding an increase in 
knowledge level but is not likely to create voluntary uptake of this information by new 
graduate nurse practitioners until required by the Board of Nursing for recertification. It 
can be expected that voluntary participation is more likely from those providers who have 
already encountered challenges related to controlled substance prescribing in their 
practice. The five-year time lapse between graduation and recertification of licensure 
leaves the new graduate nurse practitioner at risk for misprescribing and ultimately poses 
patient safety risks.    
Implications for Practice. When the curriculum was audited, information 
pertaining to controlled substance prescribing was found in one online voice-over 
PowerPoint and only one test question throughout Belmont University’s family nurse 
practitioner program pertained to controlled substance prescribing. Part of the solution to 
the identified knowledge gap could be better integrating this content into graduate level 
curriculum and enforcing it throughout multiple courses. This will better prepare students 
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to recognize the wide range of comorbidities that often parallel SUD in controlled 
substance seeking patients, such as co-occurring mental health issues.  
Graduate level learning is highly motivated by what content is tested on exams 
and national certification boards. In the future, if more emphasis is placed on the 
importance of this topic, it is likely graduate level students will focus on and retain this 
content into active clinical practice. CPH is working downstream to identify health care 
providers who have already been recognized as having improper prescribing habits. 
Integrating this content into graduate level education would work on the forefront as 
early intervention and likely prevent mandated remediation by licensing bodies.  
Strengths and Limitations. One strength of this study is that it demonstrates the 
effectiveness of the educational intervention in improving participant knowledge. It also 
evaluates new graduate nurse practitioners who have not yet been required to complete 
controlled substance continuing education, required by the state of Tennessee. 
Information pertaining to this specific group of nurse practitioners is unique because it 
reflects these providers relying solely on the education they received in graduate school 
to make clinical decisions. A gap in knowledge was identified between the Pre and Post-
Tests, suggesting opportunity for further learning, specifically related to screening and 
referral for the treatment of SUD. This information clarifies what improvements could be 
made to better prepare nurse practitioners for clinical practice.  Another strength of this 
study is the full-bodied content within the educational modules created by CPH.  
One limitation of this study is the small sample size composed of graduates of 
only one educational institution. Due to this, it is questionable if the results of this study 
are generalizable to the greater population of new graduate nurse practitioners. Future 
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research efforts should involve sampling from graduates of other educational institutions 
throughout Tennessee and ultimately the United States. 
 It is also noted that the immediate assessment of knowledge post-intervention, is 
not necessarily indicative of knowledge retention long-term. Future research efforts 
should include fully employing Level 4-Results of the Kirkpatrick Evaluation Model, and 
evaluate the long-term results of the educational intervention. While this study shows an 
immediate post-intervention increase in knowledge it is unknown at this time if the 
participants will retain the information long-term. Future efforts would involve 
evaluating the long-term retention of knowledge and the practical application of the self-
reported intent to change clinical practice by participants. Another recommendation is to 
display the correct answer and rationale to Pre and Post-Test questions after completion. 
By providing constructive feedback participant long-term knowledge retention and 
clinical practice may by influenced.  
One final limitation would include the limited number of module assessment 
questions that may not accurately capture comprehensive knowledge pertaining to 
controlled substances. However, assessment items were written to assess high-level 
learning requiring content recall, application, and analysis. A more lengthy assessment of 
learning may contribute to response fatigue and increase attrition.  
Conclusion 
Six new providers reported considering leaving or leaving a job due to controlled 
substance practices, thirteen reported experiencing pressure from patients to prescribe, 
and only seventeen reported having protocols in place surrounding the prescribing of 
controlled substances. Over 60% of participants reported feeling prepared to prescribe 
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controlled substances with confidence, however, after completing the online educational 
intervention over three fourths of the sample reported the intent to make a practice related 
change. These data suggest new graduate nurse practitioners may be vulnerable to the 
professional risks of misprescribing, leaving their patients vulnerable to iatrogenic 
addiction, overdose, and accidental death.  
 These results offer strong support that additional resources in the form of 
continuing education are needed before the mandated five-year recertification 
requirement. This study found a significant increase in knowledge surrounding controlled 
substance prescribing after completing the online educational intervention. However, the 
difficulty arises in creating motivation in new providers to seek additional resources 
before it is mandated by the state board for recertification or by law for remediation due 
to improper prescribing practices.  
 With over 50% of opioid prescriptions originating in primary care and 83.4% of 
nurse practitioners being certified in areas of primary care it is essential to better educate 
and prepare new graduates on how to properly prescribe controlled substances (Hudspeth, 
2016; American Association of Nurse Practitioners, 2016). The CDC has taken action by 
releasing The CDC Guideline for Prescribing Opioids for Chronic Pain but this alone 
does not address many of the reported issues surrounding controlled substance 
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Table 1.  Demographics  
Variable N (%)  Mean  
Clinical Practice Setting 22  
Urgent Care 2 (9.1%)  
Primary Care 7 (31.8%)  
Pain Management 1 (4.5%)  
Specialty Practice 6 (26.1%)   
Other 6 (26.1%)  
Clinical Practice Location 22  
Rural 9 (40.9%)  
Urban 13 (59.1%)  
Years of Active Clinical 
Practice  
22 2.14 
0-12 Months 7 (31.8%)  
13 months-2 years 10 (45.5%)  
25 months – 3 years 1 (4.5%)  
37 months – 4 years 3 (13.6%)  
49 months – 5 years 1 (4.5%)   




Adult 8 (36.4%)  
Geriatric 2 (9.1%)  
Pediatric 1 (4.5%)  
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Mixed Primary Care 5 (22.7%)  
Other  6  (27.3%)   
Length of Time at 
Current Practice 
22 1.73 
0-12 Months 11 (50%)  
13-24 Months 8 (36.4%)  
25-36 Months 1 (4.5%)  
37-48 Months 2 (9.1%)   
 
Table 2. Paired t-Test  
Paired Samples Statistics Module 1  




5.00 22 1.195 .255 
Total Module 
1 Post-Test 
6.59 22 .590 .126 
 
Paired Samples Test Module 1  
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Paired Samples Statistics Module 2 




2.45 22 .739 .157 
Total Module 
2 Post-Test 
4.64 22 .581 .124 
 
Paired Samples Test Module 2 





















12.872 21 .000 
 
 
Table 3. Shapiro-Wilk Test of Normality  
 Statistic df Sig . 
Total Mod2Post .645 22 .000 
Total Mod2Pre .846 22 .003 
Total Mod1Pre .920 22 .078 
Total Mod1Post .677 22 .000 
 
Table 4. Wilcoxon Matched-Pairs Test  
 
Test Statistics (a) 
 
 Total Module 1 Post- 
Total Module 1 Pre 
Total Module 2 Post-   
Total Module 2 Pre 
Z -3.742 (b) -4.181 (b) 
Asymp. Sig (2-tailed) < .001* < .001* 
(a) Wilcoxon Signed Ranks Test 
(b) Based on negative ranks 
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Table 5. Module 1 Item Analysis  
 
Item % Correct Pre % Correct Post % Gain  
1 82 (N=18) 100 (N=22) 18 
2 41 (N=9) 86 (N=22) 45 
3 5 (N=1)  0 (N=0) -5 
4 59 (N=13) 91 (N=20)  32 
5 73 (N=16) 18 (N=4) -45 
6 82 (N=18) 100 (N=22) 18 
7 91 (N=20)  100 (N=22) 9 




Table 6. Module 2 Item Analysis  
 
Item % Correct Pre % Correct Post % Gain  
1 100 (N=22) 100 (N=22) 0 
2 45 (N=10) 86 (N=19) 40 
3 45 (N=10) 95 (N=21) 50 
4 14 (N=3) 86 (N=19)  72 
5 41 (N=9) 95 (N=21) 55 
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Appendix A  
Course Surveys  
Module 1 Pre/Post Test 
1. Pain can be classified into three main classifications. Which option lists the correct classifications of pain?  
a) Central, peripheral, and complex regional    
b) Neurologic, musculoskeletal, and central    
c) Bone pain, soft tissue pain, and organ-based pain    
d) Neuropathic pain, nociceptive pain and psychogenic pain    
e) None of the above    
f) I don’t know    
2. Trigeminal neuralgia would best be classified into what category of pain?  
a) Psychogenic    
b) Soft tissue    
c) Central and peripheral    
d) Inflammatory    
e) All of the above    
f) I don’t know    
3. Dr. Moab is a 35 yo male physician in family medicine. He is a healthy young man who abstains from alcohol for religious reasons 
and has never used illicit street drugs. Dr. Moab presents to your urgent walk-in clinic after falling while hiking in Utah on a 
family vacation 3 days ago. His fall resulted in a pretty badly bruised right hip/trochanteric area, a right twisted ankle and a 
right lateral knee injury with bruising and superficial lacerations. He also has several lacerations on his right hand. His pain is 
7/10. How would you best classify Dr. Moab’s pain based on time?  
a) Acute    
b) Semi-acute    
c) Intermittent    
d) Chronic    
e) I don’t know    
4. How would you best classify Dr. Moab’s source of pain?  
a) Neuropathic    
b) Somatic    
c) Visceral    
d) Complex regional pain syndrome    
e) I don’t know    
5. Mr. L presents with acute low back pain after moving a dresser. His pain is 5/10 that he describes as dull and achy with muscle 
spasms. He has tenderness along the paraspinal muscles. Which adjuvant would be a good addition to pain control and PT?  
a) SNRI    
b) Pain rehabilitation    
c) TENS unit    
d) Bisphosphonates    
e) Sympathetic nerve block    
f) I don’t know    
6. Mr. C   presents with 7 days of 9/10 neck pain and stiffness after swimming at the start of summer. He doesn’t like taking 
medications so has not tried anything and has mildly elevated LFTs. What would be an appropriate first line treatment for this type of 
pain?  
a) Acetaminophen   
b) Cyclobenzaprine  
c)  Hydrocodone  
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d) Naproxen sodium    
e) Codeine    
f) None of the above    
g) I don’t know    
7. Ms. T is an office receptionist who complains of a pain that “radiates down” her right leg into her foot/great toe for 4 days. The pain 
started as a mild ache in her back and then developed into a burning sensation. Sometimes it feels like an electric shock if she coughs or 
sneezes. She also notes that prolonged sitting makes it worse. She denies fever, rash, bowel/bladder changes or leg weakness and no 
acute traumas. What is your most likely diagnosis?  
a) Zoster 
b)   Avascular necrosis of the femoral head  
c) Diabetes – peripheral neuropathy  
d) Sciatica   
e) I don’t know  
8. Ms. J has chronic low back pain. She did not tolerate OTC NSAIDs and has hepatitis C. You referred physical therapy and she is 
compliant but not significantly improved. What would be an appropriate next step if you follow the TN chronic non-malignant pain 
guidelines algorithm?  
a) Discharge from the office practice    
b) Start an opioid at low dose    
c) Screen for SU with UDT and check the drug monitoring program    
d) Tell the patient the pain is complicated and requires treatment from an interventionist    
e) None of the above    
f) I don’t know    
 
Module 2 Pre/Post-Test 
1)  A 32 yo female patient presents with hematuria x 3 weeks, mild right flank pain x 3 days, and nausea without vomiting x 1 day. 
She states the pain is 3-5/10 at best and 7/10 at the worst. Currently, she is comfortable, pain level is 3/10 and she has not taken any 
pain meds up to this time. The CT demonstrates 2 renal stones in the right ureter without obstruction and hydronephrosis, as well as 2 
stones in the renal pelvis. If we prescribe CPD for this patient, what proper prescribing practices should be followed?  
a) Screen this patient for substance use.    
b) Check the prescription drug monitoring program for your state.    
c) Discuss contraception prior to prescribing CPD.    
d) Discuss risk of dependence using a CPD.    
e) All of the above    
f) None of the above    
g) I don’t know    
2)  Which patients, if any, would you screen using SBIRT?  
a) Pt is a 16 yo male with non-tender white patches in his mouth. They have been there for about 3 months.    
b) Pt is a 23 yo female nursing student who blacked out after a night of partying and comes in for a superficial   laceration on 
her right forearm.    
c) Pt is 44 yo homeless male requesting hydrocodone for his migraine HA.    
d) Pt is 32 yo female with pain post-op day #1. Her friend suggested hydrocodone.    
e) All of the above    
a) None of the above    
b) I don’t know    
3)  A patient calls in early for refills twice in the past 4 months and the UDS is positive for marijuana. Which tool can you use to 
assess for a substance use disorder?  
a) The MMSE    
b) CAGE-AID    
c) BMP    
d) Confirmatory UDT  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e) All of the above    
f) None of the above    
g) I don’t know    
 
4)  What are the four steps in the four step approach to systematically prescribing CPDs in your practice?  
a) SBIRT, check the PDMP, consent and document    
b) Check family history, PDMP, UDS and document    
c) Subjective/Objective, SBIRT, Assessment/Plan and document    
d) HPI, pain levels, UDS and document    
e) Screen for PDMP, UDS, CPD use and ORT    
f) I don’t know    
5)  Which of the following screening/monitoring tools can be used for patient on CPDs?  
a) UDS, PDMP, Cage-AID, ORT, COMM    
b) COMM, Audit, T-ACE, 5-A’s    
c) ORT, UDS, CRAFFT and SOAPP-R    
d) PDMP, MAST, Assist, Audit, T-ACE    





Course Evaluation  
1. How would you rate the overall quality of the activity? 
a. Poor 
b. Average 
c. Excellent  
d. Comments:  
 
2. How valuable was the activity to you as an individual? 
a. No value at all 
b. Valuable 
c. Extremely Valuable  
d. Comments:  
 
3. How well did this activity meet your needs? 
a. Did not meet my needs 
b. Somewhat met my needs 
c. Completely met my needs 
d. N/A 
4. What did you value or like most about this activity? 
a. Comments:  
 
5. What about this activity can be improved?  
a. Comments:  
 
6. Based on your participation in this activity, how likely are you to make a practice related change? 
a. Will definitely make a change 
b. Will probably make a change 
c. Will probably NOT make a change 
d. Will definitely NOT make a change 
e. Not applicable  
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7. Based on your participation in this activity, how likely are you to make a personal related change?  
a. Will definitely make a change 
b. Will probably make a change 
c. Will probably NOT make a change 
d. Will definitely NOT make a change  
e. Not applicable  





1. What is your clinical practice setting  
a. Urgent Care 
b. Primary Care  
c. Pain Management 
d. Specialty Practice  
e. Other ______________________________ 
 
2. What is your clinical practice location 
a. Rural area  
b. Urban area  
c. Other _______________________________ 
 
3. Years of active clinical practice  
a. ___________________________ 
 
4. Primary patient population 
a. Adult 
b. Geriatric  
c. Pediatric 
d. Family Practice 
e. Other ________________________________ 
 
5. State of Practice  
a. _____________ 
 
6. Year and month of graduation  
a. __________________________ 
 
7. Length of time at current practice site  
a. _________________________________ 
 
8. Select which best describes your practice organization  
a. Work in private practice with supervising physician available by phone 
b. Work with a group of nurse practitioners with supervising physician available by phone  
c. Work with supervising physician available on site  
d. Other ____________________________________________ 
 
9. Does your practice have protocols in place guiding practice around prescribing controlled substances?  
a. Yes 
b. No  
10. Have you left a job or considered leaving your job because of controlled substance prescribing practices or expectations at 
the site? 
a. Yes  
b. No 
c. If yes, (enter skip logic)  
11. Which of the following best describes your greatest challenge related to prescribing controlled substances?  (check all that 
apply)  
a. Pressure from supervising physician  
b. Pressure/demand from patients  
c. Continuing a standing prescription written by another provider  
d. Treating co-occurring pain & mental health  
e. Other______________ 
12. Do you feel that your graduate level pharmacology class prepared you to prescribe controlled substances with confidence? 
a. Yes 
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Appendix B  
Electa Live Access Instructions 
Electa Live Access Instructions 
1. Open e-mail from noreply@school-network.net  
2. Clink on URL link 
3. Copy & paste username & password into appropriate boxes  
4. Click “Login”  
5. Select “Resource Library”  
6. Select “Module 1- Overview of Pain” PowerPoint 
7. Download to computer 
8. Open PowerPoint 
9. Read slides 
10. Click the survey links on the slide 
11. Complete the surveys in the order listed  
12. Repeat steps 7-11 for “Module 2- Best Practice” PowerPoint 
 
 
 
 
 
 
 
 
 
 
 
